ACC2, His-Tag Recombinant

ACC2, His-Tag Recombinant

Proteins & Peptides

Article No

BPS-50201

Species Reactivity

human

Size

10 µg

Source / Host

insect

Shipping Information

-80°C (dry ice)

Article No

BPS-50201

Species Reactivity

human

Size

10 µg

Source / Host

insect

Shipping Information

-80°C (dry ice)

Specifications

MW 277 kDa
Accession Number NM_001093
Additional Information Human acetyl-Coenzyme A carboxylase alpha transcript variant 2 (ACC2), GenBank Accession No. NM_001093, full length, with C-terminal His-tag, MW=277 kDa, expressed in a Baculovirus infected Sf9 cell expression system.
Article No BPS-50201
Country Availability SE, FI, DK, NO, IS, EE, LV, LT
Description ACC2, His-Tag Recombinant
Supplier BPS Bioscience
Entrez Gene ID 32
Format Aqueous buffer solution
Gene Symbol ACACB
Notes Human acetyl-Coenzyme A carboxylase alpha transcript variant 2 (ACC2), GenBank Accession No. NM_001093, full length, with C-terminal His-tag, MW=277 kDa, expressed in a Baculovirus infected Sf9 cell expression system.
Alias Names acetyl-Coenzyme A carboxylase alpha transcript variant 2, ACC-2, ACC 2, ACC -2
Product Type Proteins & Peptides
Protocol A 25 µl ACC2 reaction is conducted in a buffer containing 30 mM HEPES (pH 7.4), 2 mM MgCl<sub>2</sub>, 2 mM potassium citrate, 1 mM DTT, 100 µM ATP, 12 mM NaHCO<sub>3</sub> and 20 µM acetyl-CoA at 30°C for 45 min. ATP reduction is detected using ADP-Glo<sup>®</sup> Luminescent Assay Platform (Promega).
Research area Metabolism
Shipping Information -80°C (dry ice)
Size 10 µg
Source / Host insect
Species Reactivity human
Storage At least 6 months at -80°C.
Substrate / Buffer 40 mM Tris pH 8.0, 110 mM NaCl, 2.2 mM KCl, 0.04% Tween-20, 20% glycerol, and 3 mM DTT.
Technical Specifications Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.
UniProt Number O00763
Product Page Updated 2024-01-09T13:23:45.900Z

Documentation

References

Show more
Shipping info
The delivery time for this item is approximately 5-8 business days. Read more